Request Study Information

After you submit your request, a staff member will contact you.There’s no obligation and our team is here to help you decide on a study that’s best for you.

A Phase II Randomised, Doubleblind, Placebo-controlled study to evaluate the efficacy, safety and tolerability of AZD6234 in participants living with overweight or obesity with Type 2 Diabetes who are on a stable dose of GLP-1 Receptor Agonist

Rovia Canton (ECIR Site), Rovia Jacksonville – Southside (ECIR Site)

We are doing this study to learn more about how safe the study drug AZD6234 is and how it affects your medical condition of overweight or obesity with type 2 diabetes when you are given the study drug AZD6234 along with a specific therapy called glucagon like peptide-1 receptor agonist (GLP-1 RA). Additional aims of the study are to better understand overweight or obesity with type 2 diabetes.

Amylin is a hormone that plays an important role in body weight management. The study drug AZD6234 can mimic amylin’s effects in the body and may aid in weight management, potentially helping with weight management and type 2 diabetes.

Enter Your Information

(All fields are required)

Study Request Form (specific)

Name(Required)

First Name Last Name

Phone Number(Required)

Email Address(Required)

Zip / Postal Code(Required)

Date of Birth(Required)

Gender(Required)

Preferred Location(Required)

Study Of Interest(Required)

Preferred Language(Required)

Are you Hispanic or Latino(Required)

Race(Required)

Select one or more options that best describe you. This information can help ensure that all populations are represented in research.

American Indian or Alaskan Native

Asian

Black or African American

Native Hawaiian or Other Pacific Islander

White or Caucasian

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and consent to receiving communications (e.g., call, SMS, text, and/or email) from ECIR and/or the research site(s) involved with the clinical trials that appear on this website. Messaging frequency varies. Message and data rates may apply. You may reply with STOP to a text message. For any help regarding messaging, please email us at [email protected]. For full details, refer to ECIR’s privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

CAPTCHA

Headquarters
3550 University Blvd South, Suite #101
Jacksonville, FL 32216

Tel: (904) 854-1354
Fax: (904) 854-1355